{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:47:31Z","timestamp":1791474451809,"version":"4.3.4"},"reference-count":68,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","award":["FORSS-932159"],"award-info":[{"award-number":["FORSS-932159"]}],"id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010805","name":"Forskningsr\u00e5det i Syd\u00f6stra Sverige","doi-asserted-by":"publisher","award":["FORSS-969108"],"award-info":[{"award-number":["FORSS-969108"]}],"id":[{"id":"10.13039\/100010805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Hyperhidrosis is associated with social and emotional stress, affecting quality of life. Microwave energy technology treats primary axillary hyperhidrosis by thermolysis of sweat glands. The successful reduction of sweating in patients with primary axillary hyperhidrosis after microwave treatment has been studied, but there is limited evidence on the psychological and long-term effects. This study examined patient- reported outcome measures including depression and anxiety in patients with primary axillary hyperhidrosis and the effect of microwave therapy on these parameters. Patients received 1 or 2 microwave-based treatments, within 3-month intervals. All patients were finally examined at approximately 1 year after the first treatment using the Hyperhidrosis Disease Severity Scale, Hyperhidrosis Quality of Life\u00a9, Dermatology Life Quality Index, and Hospital Anxiety and Depression Scale\u00a9. A total of 103 individuals with primary axillary hyperhidrosis were included in the study, with a Hyperhidrosis Disease Severity Scale score of 3 or 4. Statistically significant improvement in quality of life, anxiety, and depression scores were observed at 1-year follow-up. The primary endpoint, Hyperhidrosis Disease Severity Scale of 2 or less 1 year after the first treatment, was achieved by 88.2% of patients. No serious adverse side effects were observed.<\/jats:p>","DOI":"10.2340\/actadv.v104.40543","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T11:03:42Z","timestamp":1725534222000},"page":"adv40543","source":"Crossref","is-referenced-by-count":7,"title":["Evaluation of Quality of Life, Anxiety, and Depression in Patients with Primary Axillary Hyperhidrosis Undergoing Treatment with a Microwave Device: One-year Follow-up"],"prefix":"10.2340","volume":"104","author":[{"given":"Maria","family":"Pissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-7195","authenticated-orcid":false,"given":"Alexander","family":"Shayesteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Wrisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6623-2682","authenticated-orcid":false,"given":"Emanuela","family":"Micu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"73235","doi-asserted-by":"crossref","unstructured":"Henning MAS, Reguant R, Jorgensen IF, Andersen RK, Ibler KS, Pedersen OB, et al. The temporal association of hyperhidrosis and its comorbidities: a nationwide hospital-based cohort study. J Eur Acad Dermatol Venereol 2022; 36: 2504-2511.","DOI":"10.1111\/jdv.18351"},{"key":"73236","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jdv.18351","DOI":"10.1111\/jdv.18351"},{"key":"73237","doi-asserted-by":"crossref","unstructured":"Ricchetti-Masterson K, Symons JM, Aldridge M, Patel A, Maskell J, Logie J, et al. Epidemiology of hyperhidrosis in 2 population-based health care databases. J Am Acad Dermatol 2018; 78: 358-362.","DOI":"10.1016\/j.jaad.2017.10.004"},{"key":"73238","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2017.10.004","DOI":"10.1016\/j.jaad.2017.10.004"},{"key":"73239","doi-asserted-by":"crossref","unstructured":"Shayesteh A, Janlert U, Brulin C, Boman J, Nylander E. Prevalence and characteristics of hyperhidrosis in Sweden: a cross-sectional study in the general population. Dermatology 2016; 232: 586-591.","DOI":"10.1159\/000448032"},{"key":"73240","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000448032","DOI":"10.1159\/000448032"},{"key":"73241","doi-asserted-by":"crossref","unstructured":"Parashar K, Adlam T, Potts G. The impact of hyperhidrosis on quality of life: a review of the literature. Am J Clin Dermatol 2023; 24: 187-198.","DOI":"10.1007\/s40257-022-00743-7"},{"key":"73242","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s40257-022-00743-7","DOI":"10.1007\/s40257-022-00743-7"},{"key":"73243","doi-asserted-by":"crossref","unstructured":"Swartling C, Naver H, Lindberg M. Botulinum A toxin improves life quality in severe primary focal hyperhidrosis. Eur J Neurol 2001; 8: 247-252.","DOI":"10.1046\/j.1468-1331.2001.00207.x"},{"key":"73244","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1046\/j.1468-1331.2001.00207.x","DOI":"10.1046\/j.1468-1331.2001.00207.x"},{"key":"73245","doi-asserted-by":"crossref","unstructured":"Shayesteh A, Janlert U, Nylander E. Hyperhidrosis - sweating sites matter: quality of life in primary hyperhidrosis according to the sweating sites measured by SF-36. Dermatology 2017; 233: 441-445.","DOI":"10.1159\/000486713"},{"key":"73246","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000486713","DOI":"10.1159\/000486713"},{"key":"73247","doi-asserted-by":"crossref","unstructured":"Henning M, Ibler K, Loft I, Jennum P, Didriksen M, Ullum H, et al. Hyperhidrosis is associated with sleep disturbances, daytime tiredness, stress, and depression: a retrospective cohort study from the Danish Blood Donor Study. J Am Acad Dermatol 2023; 88: 196-197.","DOI":"10.1016\/j.jaad.2022.03.063"},{"key":"73248","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2022.03.063","DOI":"10.1016\/j.jaad.2022.03.063"},{"key":"73249","doi-asserted-by":"crossref","unstructured":"Klein SZ, Hull M, Gillard KK, Peterson-Brandt J. Treatment patterns, depression, and anxiety among US patients diagnosed with hyperhidrosis: a retrospective cohort study. Dermatol Ther (Heidelb) 2020; 10: 1299-1314.","DOI":"10.1007\/s13555-020-00439-y"},{"key":"73250","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1007\/s13555-020-00439-y","DOI":"10.1007\/s13555-020-00439-y"},{"key":"73251","doi-asserted-by":"crossref","unstructured":"Shayesteh A, Gerdsdorff F, Persson M, Brulin C, Nylander E. Navigating in the fog: facing delays, rejection and ignorance when seeking help for primary hyperhidrosis. Int J Qual Stud Health Well-being 2021; 16: 1930642.","DOI":"10.1080\/17482631.2021.1930642"},{"key":"73252","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1080\/17482631.2021.1930642","DOI":"10.1080\/17482631.2021.1930642"},{"key":"73253","doi-asserted-by":"crossref","unstructured":"Naeini FF, Saffaei A, Pourazizi M, Abtahi-Naeini B. Histopathological evidence of efficacy of microneedle radiofrequency for treatment of axillary hyperhidrosis. Indian J Dermatol Venereol Leprol 2015; 81: 288-290.","DOI":"10.4103\/0378-6323.154789"},{"key":"73254","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.4103\/0378-6323.154789","DOI":"10.4103\/0378-6323.154789"},{"key":"73255","doi-asserted-by":"crossref","unstructured":"Zhang Y, Gong YY, Tang YL, Bai YS, Yang K, Chen HY, et al. Clinical efficacy of microwave in the treatment of axillary osmidrosis and primary hyperhidrosis. Dermatol Ther 2022; 35: e15657.","DOI":"10.1111\/dth.15657"},{"key":"73256","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/dth.15657","DOI":"10.1111\/dth.15657"},{"key":"73257","unstructured":"Lupin M, Hong HC, O'Shaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Surg 2014; 40: 805-807."},{"key":"73258","doi-asserted-by":"crossref","unstructured":"Johnson JE, O'Shaughnessy KF, Kim S. Microwave thermolysis of sweat glands. Lasers Surg Med 2012; 44: 20-25.","DOI":"10.1002\/lsm.21142"},{"key":"73259","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/lsm.21142","DOI":"10.1002\/lsm.21142"},{"key":"73260","doi-asserted-by":"crossref","unstructured":"Abtahi-Naeini B, Naeini FF, Saffaei A, Behfar S, Pourazizi M, Mirmohammadkhani M, et al. Treatment of primary axillary hyperhidrosis by fractional microneedle radiofrequency: is it still effective after long-term follow-up? Indian J Dermatol 2016; 61: 234.","DOI":"10.4103\/0019-5154.177789"},{"key":"73261","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.4103\/0019-5154.177789","DOI":"10.4103\/0019-5154.177789"},{"key":"73262","doi-asserted-by":"crossref","unstructured":"Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, et al. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol 2004; 51: 274-286.","DOI":"10.1016\/j.jaad.2003.12.029"},{"key":"73263","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2003.12.029","DOI":"10.1016\/j.jaad.2003.12.029"},{"key":"73264","doi-asserted-by":"crossref","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"73265","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1365-2230.1994.tb01167.x","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"73266","doi-asserted-by":"crossref","unstructured":"Basra MK, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology 2015; 230: 27-33.","DOI":"10.1159\/000365390"},{"key":"73267","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1159\/000365390","DOI":"10.1159\/000365390"},{"key":"73268","doi-asserted-by":"crossref","unstructured":"Kamudoni P, Mueller B, Halford J, Schouveller A, Stacey B, Salek MS. The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation. Health Qual Life Outcomes 2017; 15: 121.","DOI":"10.1186\/s12955-017-0693-x"},{"key":"73269","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1186\/s12955-017-0693-x","DOI":"10.1186\/s12955-017-0693-x"},{"key":"73270","doi-asserted-by":"crossref","unstructured":"Gabes M, Jourdan C, Schramm K, Masur C, Abels C, Kamudoni P, et al. Hyperhidrosis Quality of Life Index (HidroQoL(c)): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial. Br J Dermatol 2021; 184: 473-481.","DOI":"10.1111\/bjd.19300"},{"key":"73271","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.19300","DOI":"10.1111\/bjd.19300"},{"key":"73272","doi-asserted-by":"crossref","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"73273","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"73274","doi-asserted-by":"crossref","unstructured":"Stern AF. The hospital anxiety and depression scale. Occup Med (Lond) 2014; 64: 393-394.","DOI":"10.1093\/occmed\/kqu024"},{"key":"73275","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1093\/occmed\/kqu024","DOI":"10.1093\/occmed\/kqu024"},{"key":"73276","unstructured":"S G. Anesthesia delivery with syringe adapter for miraDry\u00ae (modified technique). [Online] Available from https:\/\/www.gerrishmedesthetics.com\/services\/miradry\/miradry-fresh-procedure-developed-by-dr-scott-gerrish\/"},{"key":"73277","doi-asserted-by":"crossref","unstructured":"Parrish C, Waldbaum B, Coleman D, Blevins C, Rodgers K, Lee B, et al. Microwave thermolysis reduces generalized and social anxiety in young adults with axillary hyperhidrosis. Lasers Surg Med 2020; 52: 842-847.","DOI":"10.1002\/lsm.23229"},{"key":"73278","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1002\/lsm.23229","DOI":"10.1002\/lsm.23229"},{"key":"73279","doi-asserted-by":"crossref","unstructured":"Hong HC, Lupin M, O'Shaughnessy KF. Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg 2012; 38: 728-735.","DOI":"10.1111\/j.1524-4725.2012.02375.x"},{"key":"73280","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/j.1524-4725.2012.02375.x","DOI":"10.1111\/j.1524-4725.2012.02375.x"},{"key":"73281","doi-asserted-by":"crossref","unstructured":"Tan Y, Huang W, Liu J, Duan Z, He X, Li Q, et al. The application of microwaves in axillary hyperhidrosis: curative effect observation of a pathological examination over 1 year. J Cosmet Dermatol 2024; 23: 134-140.","DOI":"10.1111\/jocd.15909"},{"key":"73282","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/jocd.15909","DOI":"10.1111\/jocd.15909"},{"key":"73283","doi-asserted-by":"crossref","unstructured":"Wang J, Wu X, Lai W, Long E, Zhang X, Li W, et al. Prevalence of depression and depressive symptoms among outpatients: a systematic review and meta-analysis. BMJ Open 2017; 7: e017173.","DOI":"10.1136\/bmjopen-2017-017173"},{"key":"73284","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1136\/bmjopen-2017-017173","DOI":"10.1136\/bmjopen-2017-017173"},{"key":"73285","doi-asserted-by":"crossref","unstructured":"Tiller JW. Depression and anxiety. Med J Aust 2013; 199: S28-31.","DOI":"10.5694\/mjao12.10628"},{"key":"73286","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.5694\/mjao12.10628","DOI":"10.5694\/mjao12.10628"},{"key":"73287","doi-asserted-by":"crossref","unstructured":"Braganca GM, Lima SO, Pinto Neto AF, Marques LM, Melo EV, Reis FP. Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis. An Bras Dermatol 2014; 89: 230-235.","DOI":"10.1590\/abd1806-4841.20142189"},{"key":"73288","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1590\/abd1806-4841.20142189","DOI":"10.1590\/abd1806-4841.20142189"},{"key":"73289","doi-asserted-by":"crossref","unstructured":"Bahar R, Zhou P, Liu Y, Huang Y, Phillips A, Lee TK, et al. The prevalence of anxiety and depression in patients with or without hyperhidrosis (HH). J Am Acad Dermatol 2016; 75: 1126-1133.","DOI":"10.1016\/j.jaad.2016.07.001"},{"key":"73290","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2016.07.001","DOI":"10.1016\/j.jaad.2016.07.001"},{"key":"73291","doi-asserted-by":"crossref","unstructured":"Kristensen JK, Moller S, Vestergaard DG, Horsten HH, Swartling C, Bygum A. Anxiety and depression in primary hyperhidrosis: an observational study of 95 consecutive Swedish outpatients. Acta Derm Venereol 2020; 100: adv00240.","DOI":"10.2340\/00015555-3598"},{"key":"73292","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.2340\/00015555-3598","DOI":"10.2340\/00015555-3598"},{"key":"73293","doi-asserted-by":"crossref","unstructured":"Shayesteh A, Boman J, Janlert U, Brulin C, Nylander E. Primary hyperhidrosis: implications on symptoms, daily life, health and alcohol consumption when treated with botulinum toxin. J Dermatol 2016; 43: 928-933.","DOI":"10.1111\/1346-8138.13291"},{"key":"73294","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/1346-8138.13291","DOI":"10.1111\/1346-8138.13291"},{"key":"73295","doi-asserted-by":"crossref","unstructured":"Ruchinskas RA, Narayan RK, Meagher RJ, Furukawa S. The relationship of psychopathology and hyperhidrosis. Br J Dermatol 2002; 147: 733-735.","DOI":"10.1046\/j.1365-2133.2002.04857.x"},{"key":"73296","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04857.x","DOI":"10.1046\/j.1365-2133.2002.04857.x"},{"key":"73297","doi-asserted-by":"crossref","unstructured":"Schut C, Dalgard FJ, Bewley A, Evers AWM, Gieler U, Lien L, et al. Body dysmorphia in common skin diseases: results of an observational, cross-sectional multicentre study among dermatological outpatients in 17 European countries. Br J Dermatol 2022; 187: 115-125.","DOI":"10.1111\/bjd.21021"},{"key":"73298","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1111\/bjd.21021","DOI":"10.1111\/bjd.21021"},{"key":"73299","doi-asserted-by":"crossref","unstructured":"Shayesteh AB, Boman J, Nylander E. Impostor phenomenon is a common feature among individuals with primary hyperhidrosis. SAGE Open Med 2024; Jan 27: 12.","DOI":"10.1177\/20503121231220828"},{"key":"73300","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1177\/20503121231220828","DOI":"10.1177\/20503121231220828"},{"key":"73301","doi-asserted-by":"crossref","unstructured":"Albucker SJ, Lipner SR. Microwave energy devices for hyperhidrosis are associated with infections, neurologic symptoms, and burns in a retrospective analysis of the Manufacturer and User Facility Device Experience database 2013-2022. J Am Acad Dermatol 2023; 89: 820-822.","DOI":"10.1016\/j.jaad.2023.06.005"},{"key":"73302","doi-asserted-by":"crossref","unstructured":"https:\/\/doi.org\/10.1016\/j.jaad.2023.06.005","DOI":"10.1016\/j.jaad.2023.06.005"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40543\/47591","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/40543\/47591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T11:04:21Z","timestamp":1725534261000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/40543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":68,"URL":"https:\/\/doi.org\/10.2340\/actadv.v104.40543","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,5]]}}}